5 Best Fast Growing Penny Stocks to Buy Now

4. Amneal Pharmaceuticals, Inc. (NYSE:AMRX)

Number of Hedge Fund Holders: 12

Bridgewater, New Jersey-based Amneal Pharmaceuticals, Inc. (NYSE:AMRX) shares have gained about 50% in value year to date through July 30. In May the company posted strong Q1 results. Adjusted EPS in the quarter totaled $0.12, surpassing estimates by $0.02. Revenue in the period jumped 12.1% year over year to $558 million, beating estimates by $15.82 million. For full-year 2023 Amneal Pharmaceuticals, Inc. (NYSE:AMRX) expects its revenue to come in at $2.25 billion to $2.35 billion, while analyst estimate for the metric is $2.33 billion.

Insider Monkey’s database of 943 hedge funds shows that 12 funds reported owning stakes in Amneal Pharmaceuticals, Inc. (NYSE:AMRX) as of the end of the first quarter. The biggest stakeholder of Amneal Pharmaceuticals, Inc. (NYSE:AMRX) during this period was Eversept Partners of Kamran Moghtaderi which owns a $7.2 million stake in the company.